Pedzisai Munatsi
Biographic Data
| ID | 8932882 |
|---|---|
| NAME | Pedzisai Munatsi |
| GIVEN NAMES | Pedzisai |
| FAMILY NAME | Munatsi |
| SIGNATURE | MUNATSI P |
| AFFILIATIONS | Centre for the AIDS Programme of Research in South Africa |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Point-of-care HIV viral load testing in a community antiretroviral therapy delivery programme
Community antiretroviral therapy (ART) delivery programmes allow people with HIV (PWH) to collect treatment nearer to home instead of from clinics. However, delays in laboratory-based viral load (VL) testing can prevent timely community ART prescription renewals. We aimed to determine if clinic point-of-care VL testing could expedite community ART prescription renewals within the Centralised Chronic Medication Dispensing and Distribution programm…
Acceptability and perspectives on clinic-based urine tenofovir testing for antiretroviral therapy adherence monitoring
Real-time, urine tenofovir testing may allow for clinic-based monitoring of adherence to antiretroviral therapy (ART). We aimed to assess (1) the acceptability of monthly point-of-care urine tenofovir testing over the first five months following ART initiation and (2) perspectives on the implementation of point-of-care urine tenofovir testing among people living with HIV (PLWH) and healthcare providers participating in a randomized controlled tri…
Healthcare worker perspectives on adaptations to differentiated anti-retroviral therapy delivery during Covid-19 in South Africa
During the COVID-19 pandemic, the South African Centralized Chronic Medicines Dispensing and Distribution (CCMDD) programme, adapted to include extended 12-month antiretroviral therapy (ART) prescriptions, 3-months ART refills and earlier eligibility criteria at 6-months after ART initiation. We aimed to explore the experiences of healthcare workers (HCWs) in implementing these adaptations, and to understand the overall impact of COVID-19 on CCMD…
No prominent works on this page.
Healthcare worker perspectives on adaptations to differentiated anti-retroviral therapy delivery during Covid-19 in South Africa
During the COVID-19 pandemic, the South African Centralized Chronic Medicines Dispensing and Distribution (CCMDD) programme, adapted to include extended 12-month antiretroviral therapy (ART) prescriptions, 3-months ART refills and earlier eligibility criteria at 6-months after ART initiation. We aimed to explore the experiences of healthcare workers (HCWs) in implementing these adaptations, and to understand the overall impact of COVID-19 on CCMD…
Point-of-care HIV viral load testing in a community antiretroviral therapy delivery programme
Community antiretroviral therapy (ART) delivery programmes allow people with HIV (PWH) to collect treatment nearer to home instead of from clinics. However, delays in laboratory-based viral load (VL) testing can prevent timely community ART prescription renewals. We aimed to determine if clinic point-of-care VL testing could expedite community ART prescription renewals within the Centralised Chronic Medication Dispensing and Distribution programm…
Acceptability and perspectives on clinic-based urine tenofovir testing for antiretroviral therapy adherence monitoring
Real-time, urine tenofovir testing may allow for clinic-based monitoring of adherence to antiretroviral therapy (ART). We aimed to assess (1) the acceptability of monthly point-of-care urine tenofovir testing over the first five months following ART initiation and (2) perspectives on the implementation of point-of-care urine tenofovir testing among people living with HIV (PLWH) and healthcare providers participating in a randomized controlled tri…
Antiretroviral therapy (3 works) · HIV/AIDS Research and Interventions (3 works) · Viral load (3 works) · Health care (2 works) · HIV, Drug Use, Sexual Risk (2 works) · Medicine (2 works) · Pathology (2 works) · Qualitative research (2 works) · Randomized controlled trial (2 works) · 2019-20 coronavirus outbreak (1 works)